Hyperferritinaemia; laboratory implications

Annals of Clinical Biochemistry

Volumn 49, Issue 3, 2012, Pages 211-213

  Crook, M A ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOFERRITIN; C PEPTIDE; CERULOPLASMIN; FERRITIN; FERROPORTIN; HEPCIDIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1ALPHA; IRON; PROTON COUPLED FOLATE TRANSPORTER; TRANSFERRIN; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

BETA THALASSEMIA; CATARACT; CHROMOSOME 11; CHROMOSOME 19; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CYTOKINE STORM; CYTOLYSIS; DIASTOLIC BLOOD PRESSURE; DRESS SYNDROME; EDITORIAL; ENDOCYTOSIS; ENZYME ACTIVITY; EXTRAHEPATIC BILE DUCT OBSTRUCTION; FAMILIAL HYPERLIPEMIA; FATTY LIVER; FERRITIN BLOOD LEVEL; GENE MUTATION; HEMOCHROMATOSIS; HEMOLYSIS; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HUMAN; HYPERFERRITINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; INSULIN RESISTANCE; INTESTINE CELL; IRON OVERLOAD; IRON STORAGE; JUVENILE RHEUMATOID ARTHRITIS; LIVER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCYTOPENIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN GLYCOSYLATION; SIDEROBLASTIC ANEMIA;

APOFERRITINS; FERRITINS; HUMANS; IRON METABOLISM DISORDERS; JAUNDICE, OBSTRUCTIVE; MALE; MUTATION, MISSENSE;

EID: 84861496737     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1258/acb.2012.012059     Document Type: Editorial

References (28)

1. Thurlow V, Vadher B, Bomford A, et al. Two novel mutations in the L ferritin coding sequence associated with benign hyperferritinaemia unmasked by glycosylated ferritin assay. Ann Clin Biochem 2012;49: 302-5
2. Marshall GA, Pretorius CJ, Ungerer JPJ. Extreme hyperferritinaemia: further considerations. Ann Clin Biochem 2012;49:306
3. Crook M, ed. Clinical Biochemistry and Metabolic Medicine. Chapter 21, 8th edn. London: Hodder Arnold, 2012:312
4. Aguilar-Martinez P, Schved JF, Brissot P. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities. Am J Gastroenterol 2005;100:1185-94
5. Hearnshaw S, Thompson NP, McGill A. The epidemiology of hyperferritinemia. World J Gastroenterol 2006;12:5866-9
6. Camaschella C, Poggiali E. Towards explaining 'unexplained hyperferritinemia'. Haematologica 2009;94:307-9
7. Finch CA, Bellotti V, Stray S, et al. Plasma ferritin determination as a diagnostic tool. West J Med 1986;145:657-63
8. Mateo-Gallego R, Calmarza P, Jarauta E, Burillo E, Cenarro A, Civeira F. Plasma ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. Metabolism 2010;59:154-8
9. Brudevold R, Hole T, Hammerstrøm J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS One 2008;3:3547
10. Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999;117:1155-63
11. Moirand R, Mortaji AM, Loréal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferring saturation. Lancet 1997;349:95-7
12. Shekunov J, De Groen PC, Lindor NM, et al. Hereditary hyperferritinemia-cataract syndrome in two large multigenerational American families. J AAPOS 2011;15:356-61
13. Rüfer A, Howell JP, Lange AP, et al. Hereditary hyperferritinemia-cataract syndrome presenting with iron deficiency anemia associated with a new mutation in the iron responsive element of the L-ferritin gene in a Swiss family. Eur J Haematol 2011;87:274-8
14. Craig JE, Clark JB, McLeod J, et al. Hereditary hyperferritinemia-cataract syndrome. Arch Opthalmol 2003;121:1753-61
15. Sanders SJ, Suri M, Ross I. Hereditary hyperferritinemia-cataract syndrome and differential diagnosis of hereditary hemochromatosis. Postgrad Med J 2003;79:600-1
16. Arnold JD, Mumford AD, Lindsay JO, Hegde U, Hagan M, Hawkins JR. Hyperferritinemia in the absence of iron overload. Gut 1997;1:408-10
17. Bertola F, Veneri D, Bosio S, Battaglia P, Disperati A, Schiavon R. Hyperferritinemia without iron overload: pathogenic and therapeutic implications. Curr Drug Targets Immune Endocrinol Metab Disord 2004;4:93-105
18. Mumford AD, Vulliamy T, Lindsay J, Watson A. Hereditary hyperferritinemia-cataract syndrome: two novel mutations in the L-ferritin iron-responsive element. Blood 1998;91:367-8
19. Cazzola M. Role of ferritin and ferroportin genes in unexplained hyperferritinemia. Best Pract Res Clin Haematol 2005;18:251-63
20. Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal plasma iron values reveal both L-ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood 2003;102:1904-10
21. Griffiths WJ, Mayr R, McFarlane I, et al. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation. Transfusion 2010;50:1144-55
22. Shabbir M, Lucas J, Lazarchick J, Shirai K. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol 2011;29:100-6
23. Campos LM, Omori CH, Lotito AP, Jesus AA, Porta G, Silva CA. Acute pancreatitis in juvenile systemic lupus erythematosus: a manifestation of macrophage activation syndrome? Lupus 2010;19:1654-8
24. Sami SS, Penston J, Hiang LT, Barlow I. Unusually high ferritin in a patient with obstructive jaundice. Ann Clin Biochem 2011;48:272-5
25. Chotoo IB, Stephen F, John J, John PB. Plasma ferritin in acute hepatocellular damage. Clin Chem 2000;46:885-6
26. Miyazaki M, Tanaka M, Ueda A, et al. Acute liver failure caused by drug-induced hypersensitivity syndrome associated with hyperferritinemia. World J Gastroenterol 2011;17:4928-31
27. Worwood M, Cragg SJ, Wagstaff M, Jacobs A. Binding of human plasma ferritin to concanavalin A. Clin Sci 1979;56:83-7
28. Fardet L, Coppo P, Kettaneh A, Dehoux M, Cabane J, Lambotte O. Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum 2008;58:1521-7